Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Eva, Segelov"'
Autor:
Robert Samuel, Stephen R. Knight, Richard Adams, Prajnan Das, Jennifer Dorth, David Finch, Marianne G. Guren, Maria A. Hawkins, Susan Moug, Lakshmi Rajdev, David Sebag-Montefiore, Andrew G. Renehan, Rebecca Fish, Miguel A. Rodriguez-Bigas, Pratik Adusumilli, Ahmed Allam Mohamed, Mario Alvarez Gallego, Eva Angenete, Ane Appelt, Maaike Berbee, Danielle Brogden, Peter Brown, Lucy Buckley, Nathalie Casanova, Rachel Cooper, Nuno Couto, Peter Coyne, Tamzin Cuming, Charlotte Deijin, Kristopher Dennis, Cathy Eng, Alexandra Gilbert, Duncan Gilbert, Karyn Goodman, Rashmi Jadon, Anders Johnsson, Arunansu Kar, Ethan Ludmir, Marie-Louise Lydrup, Ivan Lyra-Gonzalez, Stefania Manfrida, Rebecca Muirhead, Sarah O'Dwyer, Thomas Rackley, Lukasz Raszewski, Leslie Samuel, Mark Saunders, Andrew Scarsbrook, Eva Segelov, Timothy Simmons, Paul Sutton, Nicholas Symons, Deborah Williamson
Publikováno v:
EClinicalMedicine, Vol 78, Iss , Pp 102939- (2024)
Summary: Variation in outcomes definitions and reporting limit the utility of clinical trial results. The Core Outcome Research Measures in Anal Cancer (CORMAC) project developed a core outcome set (COS) for chemoradiotherapy trials for anal squamous
Externí odkaz:
https://doaj.org/article/13141decd4db43eeae1e82431775d0e8
Autor:
Laure-Anne Teuwen, Joanna Young, Saleh Alessy, Berna C. Özdemir, Diah Martina, Sharif Folorunso, Maria T. Bourlon, Hans Prenen, Eva Segelov
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSEMultiple disparities have been recognized in the area of location, gender, and funding for leadership in oncology clinical trials. Understanding their intersectionality is crucial to be able to formulate policies and actions, to ensure researc
Externí odkaz:
https://doaj.org/article/2721b36d7b2d4bfeb1fe2412bc9a3718
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
Time to update abstract submission categories to promote dissemination of global oncology research.
Externí odkaz:
https://doaj.org/article/b516da2679a44938912c5c980cec07be
Autor:
Holly Wang, Lisa Grech, Jennifer Wong, David Hoffman, Barbora de Courten, Brett Sillars, Mark Savage, Alastair Kwok, Mike Nguyen, Nathan Bain, Daphne Day, Eva Segelov, on behalf of the DIABVACCS Investigators
Publikováno v:
Vaccines, Vol 12, Iss 6, p 662 (2024)
Background: This study explored vaccination hesitancy, diabetes-specific COVID-19 vaccination concerns, and whether they predicted vaccination uptake in people with diabetes. Methods: Quantitative, cross-sectional, and predictive approaches were used
Externí odkaz:
https://doaj.org/article/92e234c7c9c04281837848683c5495e9
Autor:
Eva Segelov
An understanding of the molecular pathogenesis of colorectal cancer by researchers and clinicians is essential to facilitate progress in improving patient outcomes in this common cancer that still carries a poor prognosis if not identified early. Thi
Autor:
Jimmy He, Christopher G. C. A. Jackson, Sanjeev Deva, Tak Hung, Katriona Clarke, Eva Segelov, Tsu‐Yi Chao, Ming‐Shen Dai, Hsien‐Tang Yeh, Wen Wee Ma, Douglas Kramer, Wing‐Kai Chan, Rudolf Kwan, David Cutler, Jay Zhi
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 7, Pp 867-879 (2022)
Abstract Oraxol consists of an oral dosage form of the chemotherapeutic agent paclitaxel administered with a novel P‐glycoprotein inhibitor encequidar methanesulfonate monohydrate (formerly named HM30181A), which allows oral treatment of cancers th
Externí odkaz:
https://doaj.org/article/6f50ac2d7cfa49bfb26f56d0d6565aae
Autor:
Diah Martina, Eva Segelov
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/18bbbdb3ee9e4b82beba54756820e600
Autor:
Daphne Day, Han Chong Toh, Raghib Ali, Estelle Mei Jye Foo, John Simes, John Whay Kuang Chia, Eva Segelov
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEThe Asia-Pacific (APAC) region is a major focus for multinational clinical trials, although its cultural, linguistic, economic, and regulatory diversity pose significant challenges for trial conduct, particularly for academic clinical trials.M
Externí odkaz:
https://doaj.org/article/d2e76334fda04eb9bb292a3b55e61b90
Autor:
Amy Body, Elizabeth Ahern, Luxi Lal, Karen Gillett, Hesham Abdulla, Stephen Opat, Tracey O’Brien, Peter Downie, Stuart Turville, C. Mee Ling Munier, Corey Smith, C. Raina MacIntyre, Eva Segelov
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Cancer is associated with excess morbidity and mortality from coronavirus disease 2019 (COVID-19) following infection by the novel pandemic coronavirus SARS-CoV-2. Vaccinations against SARS-CoV-2 have been rapidly developed and pr
Externí odkaz:
https://doaj.org/article/8b813284b7c74424a818cf795772aacf
Autor:
Marianne S. Elston, Amanda Love, Dev Kevat, Richard Carroll, Zhen Rong Siow, Sharon Pattison, Veronica Boyle, Eva Segelov, Andrew H. Strickland, David Wyld, Richard Gauci, Kim Kennedy, David Ransom, the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs)
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8405-8411 (2021)
Abstract Peptide receptor radionuclide therapy (PRRT) is an increasingly used treatment for unresectable neuroendocrine tumours (NETs) that express somatostatin receptors. Normal pituitary tissue expresses somatostatin receptors so patients receiving
Externí odkaz:
https://doaj.org/article/023c9ccd95dd41eba7390ebfa9e2d272